financetom
Business
financetom
/
Business
/
Spanish beauty group Puig posts 14% rise in holiday sales
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Spanish beauty group Puig posts 14% rise in holiday sales
Jan 30, 2025 10:24 AM

MADRID, Jan 30 (Reuters) - Spanish fashion and fragrance

company Puig reported a 14.3% rise in fourth-quarter

sales on Thursday, beating analyst expectations for the key

holiday period.

The Barcelona-based company behind perfume brands Rabanne,

Carolina Herrera and Jean Paul Gaultier said net sales for the

three months to Dec. 31 were 1.36 billion euros ($1.42 billion),

above the 1.30 billion euro average forecast from analysts

polled by LSEG.

Puig, which generates most of its revenue from fragrance

sales, is heavily reliant on the holiday season, with analysts

estimating that nearly half of its prestige perfumes are sold in

the quarter that includes Black Friday and Christmas.

The company, which also owns luxury skincare and make-up

brands Byredo and Charlotte Tilbury, said full-year sales

reached 4.79 billion euros ($4.99 billion), up 11% from 2023,

surpassing its goal of increasing sales faster than the 6-7%

forecast for the global premium beauty market.

The average of analyst estimates was for sales of 4.72

billion euros in 2024, given that it is less exposed to sluggish

demand in China and that more than half of Puig's revenue comes

from Europe, the Middle East and Africa while 18% comes from the

United States.

The 2024 performance of larger rivals such as Estee Lauder ( EL )

and L'Oreal was hampered by muted demand from

China, where a property crisis and high youth unemployment have

curbed consumer spending.

Puig said sales in its core fragrance and fashion business

grew by 21% in the holiday quarter.

Sales in the make-up division fell 7.2%, with its Charlotte

Tilbury brand affected by a voluntary withdrawal of select

batches of Airbrush Flawless Setting Spray in December over what

Puig described as "an isolated quality issue in a limited number

of batches" detected during routine product testing.

($1 = 0.9599 euros)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved